SupplySide Global
NutriLeads to Showcase Latest Research on Benicaros Precision Prebiotic
A new study found that four weeks of supplementation with the RG-I supplement supported microbiome balance, innate immune response, and SCFA production.
By: Mike Montemarano
Associate Editor, Nutraceuticals World
Photo: nukies1234 | Adobe Stock
Booth 6173
NutriLeads will highlight new clinical findings and showcase product examples of its precision prebiotic fiber Benicaros at SupplySide Global.
“We look forward to sharing our latest research and product application examples at SupplySide Global,” said Sue McKay, PhD, nutrition & health manager at NutriLeads. “Benicaros continues to stand out because of its robust science demonstrating consistent benefits for all gut ecosystems and for immune health.”
A recent randomized, double-blind, placebo-controlled clinical study published in Microorganisms evaluated the effects of four weeks of Benicaros (carrot rhamnogalacturonan-I (RG-I)) supplementation in healthy adults. The study assessed microbiota composition, metabolic activity, immune cell activation, and gut health outcomes with validated questionnaires.
The results showed a rapid prebiotic effect with significant increases in Bifidobacteria which peaked at week three. The supplement also appeared to prime dendritic cells, suggesting innate immune training. Benicaros balanced microbiota even in participants who were already consuming fiber-rich diets, and improved stool consistency.
Additional lab studies also showed that Benicaros and its fermentation products, such as short-chain fatty acids, helped to protect the gut barrier under stress and inflammatory conditions.
“This second clinical intervention study confirms gut and immune health benefits of Benicaros and strengthens the evidence for its additional role in protecting the gut barrier,” said McKay.


